Rocket Lab’s $266 Million Hypersonics Win Leaves Investors Asking: Is It Enough?

Rocket Lab secures its largest launch deal from the U.S. Space Force, but shares remain under pressure amid acquisition fears and insider selling.

A freshly inked Pentagon contract worth $266 million—the largest launch deal in Rocket Lab’s history—sent shares climbing 4.63% on Monday to close at €58.80. Yet that single-day bounce barely dents the damage inflicted over the past month, during which the stock has shed 31.63% of its value. The disconnect between operational milestones and market sentiment has rarely been starker for the space company.

The Space Systems Command of the U.S. Space Force awarded Rocket Lab the contract under the Rocket Systems Launch Program, covering up to 18 suborbital missions from the Pacific Spaceport Complex in Kodiak, Alaska. Twelve launches are firm commitments, with options for six more extending into 2028. The modified Electron rocket, designated HASTE, will carry payloads of up to 1,500 pounds at speeds exceeding Mach 5, supporting hypersonic and missile defense testing. CEO Peter Beck framed the award as a vote of confidence from the military, noting it builds on a separate four-year, $190 million Pentagon agreement signed in March for 20 hypersonic test flights.

The contract marks a strategic pivot. Rocket Lab is evolving from a niche provider of small satellite launches into a go-to defense partner, with the Alaska facility complementing existing sites in New Zealand and Virginia. The company’s recent Victus Haze mission for the Space Force underscored this shift: an Electron rocket delivered a satellite to orbit just 16 hours and 42 minutes after final launch authorization, with the spacecraft operational within 38 hours and closing on a target in under 59. For the first time, Rocket Lab served as sole prime contractor for the rocket, spacecraft, and operations—a capability analysts view as a distinct competitive advantage in the defense market.

But the stock’s slide tells a different story. At current levels around €57.40, shares have tumbled 2.38% on the day and sit 57.10% below the 52-week high of €133.80 reached on May 27. The catalyst was the late-June announcement of Rocket Lab’s $8 billion acquisition of Iridium Communications, financed in part through a $3.6 billion bridge loan. Iridium shareholders are set to receive $54 per share in a mix of cash and stock, but the deal has sparked fears of dilution and elevated debt loads among Rocket Lab investors.

The financials offer some reassurance. First-quarter revenue hit $200.3 million, up 63% year-over-year, with a net loss of $45 million. The backlog stood at $2.2 billion, and second-quarter guidance called for $225 million to $240 million in revenue. Yet the market remains skeptical, with insider selling adding to the unease—Beck himself unloaded nearly one million shares in early July, even as the Public Employees Retirement System of Ohio boosted its stake by 14.4% in the first quarter.

Analyst opinions diverge sharply. Citizens maintains a “Market Outperform” rating with a $130 price target, citing sustained launch demand and progress on the Neutron rocket. Piper Sandler initiated coverage at “Neutral” with a more modest $83 target. The average analyst consensus sits well above the current trading level, suggesting the market is pricing in considerable risk.

Meanwhile, Rocket Lab continues development of the Neutron launch vehicle. A recent test of the Archimedes engine generated nearly 1.5 million pounds of thrust, though the timeline for the debut flight has slipped due to a fuel tank crack. Beck has stressed that technical readiness takes precedence over deadlines, but the first flight remains targeted for later this year. Two events loom large: the August 10 earnings report, where investors will seek updates on the Iridium integration and Archimedes certification, and the Neutron maiden voyage in the fourth quarter, which will test whether the company can deliver operationally on the promise of its growing order book.

For now, the Space Force contract provides a near-term floor. Whether that foundation holds depends on Rocket Lab proving it can execute at scale—and convince the market that the Iridium gamble will pay off.